Insulin Glargine - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

France protests trigger 1,800 arrests as Macron faces nationwide crisis

Editorial infographic showing humanoid and industrial robots in a warehouse, with digital-twin mapping and key figures on commissioning, picking accuracy, operating hours and robotics orders.

Can physical AI escape the demo stage and become real industrial infrastructure?

Modal Labs has secured $750 million in Series D funding at a $15.75 billion valuation, marking a nearly 239% valuation surge in five months as demand for AI inference, GPU cloud infrastructure and autonomous coding agents accelerates, pushing the company's annualized run rate beyond $1 billion. Representative image.

Modal valuation jumps 239% as AI infrastructure demand drives $750m Series D

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Read More

Pharma Industry News

Biocon Biologics, Viatris launch interchangeable biosimilars in US

Biocon Ltd. said that its subsidiary — Biocon Biologics and Viatris have launched interchangeable biosimilars SEMGLEE (insulin glargine-yfgn)…

November 16, 2021

web analytics